sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Category : Pharmaceuticals and Healthcare QY Research Pages :116
Published Date : 2018-11-20

 

This report studies the global market size of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in these regions. This research report categorizes the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. In 2017, the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market based on company, product type, application and key regions. The various contributors involved in the value chain of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs include Astellas Pharmaceuticals Actavis Pfizer GlaxoSmithKline Salix Pharmaceuticals Ltd AstraZenenca Market Size Split by Type Preface Eluxadoline Alosetron Rifaximin Loperamide Diphenoxylate + Atropine Dicyclomine and Hyoscyamine Market Size Split by Application Hospitals Clinics Others Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Type 1.4.2 Preface 1.4.3 Eluxadoline 1.4.4 Alosetron 1.4.5 Rifaximin 1.4.6 Loperamide 1.4.7 Diphenoxylate + Atropine 1.4.8 Dicyclomine and Hyoscyamine 1.5 Market by Application 1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Application 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size 2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue 2016-2025 2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2025 2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Growth Rate by Regions 2.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions 2.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers 3.1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers 3.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers 3.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers 3.2.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2016-2018) 3.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2016-2018) 3.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturers 3.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturing Base Distribution, Product Types 3.4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category 3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type 4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type 4.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Breakdown Data by Application 6 North America 6.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries 6.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries 6.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 6.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 6.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company 7 Europe 7.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries 7.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries 7.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 7.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 7.4 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company 8 Asia Pacific 8.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries 8.1.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries 8.1.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 8.3 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 8.4 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company 9 Central & South America 9.1 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries 9.1.1 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries 9.1.2 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 9.3 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 9.4 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company 10 Middle East and Africa 10.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Countries 10.1.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries 10.1.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type 10.3 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Application 10.4 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company 11 Company Profiles 11.1 Astellas Pharmaceuticals 11.1.1 Astellas Pharmaceuticals Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.1.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.1.5 Recent Development 11.2 Actavis 11.2.1 Actavis Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.2.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.2.5 Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.3.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.3.5 Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.4.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.4.5 Recent Development 11.5 Salix Pharmaceuticals Ltd 11.5.1 Salix Pharmaceuticals Ltd Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.5.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.5.5 Recent Development 11.6 AstraZenenca 11.6.1 AstraZenenca Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs 11.6.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Description 11.6.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material 13.1.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share by Types (Product Category) in 2017 Figure Preface Product Picture Table Major Manufacturers of Preface Figure Eluxadoline Product Picture Table Major Manufacturers of Eluxadoline Figure Alosetron Product Picture Table Major Manufacturers of Alosetron Figure Rifaximin Product Picture Table Major Manufacturers of Rifaximin Figure Loperamide Product Picture Table Major Manufacturers of Loperamide Figure Diphenoxylate + Atropine Product Picture Table Major Manufacturers of Diphenoxylate + Atropine Figure Dicyclomine and Hyoscyamine Product Picture Table Major Manufacturers of Dicyclomine and Hyoscyamine Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Growth Rate by Application 2018-2025 (K Units) Figure Hospitals Figure Clinics Figure Others Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Report Years Considered Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size 2016-2025 (Million US$) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales 2016-2025 (K Units) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions 2016-2025 (K Units) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions 2016-2025 Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions 2016-2025 Figure 2017 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions 2016-2025 (Million US$) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2016-2025 Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2016-2025 Figure 2017 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2016-2018) (K Units) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers (2016-2018) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers in 2017 Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturers (2016-2018) (Million US$) Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2016-2018) Figure Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value Share by Manufacturers in 2017 Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (2016-2018) (USD/Unit) Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Category Table Date of International Manufacturers Enter into Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2016-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type in 2017 Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2016-2025) (Million US$) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2016-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type (2016-2025) Figure Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Type in 2017 Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type 2013-2018 (USD/Unit) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2016-2025) Figure Global Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2016-2025) Figure Global Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2016-2025) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2025 (K Units) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2025 (Million US$) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2016-2025) (K Units) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2016-2025) Figure 2017 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2016-2025) (Million US$) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure 2017 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2016-2025) Figure 2017 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2018) (K Units) Table North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2018) Figure North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2017 Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2025 (K Units) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2016-2025) (K Units) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2016-2025) (Million US$) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (K Units) Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (K Units) Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure 2017 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2016-2025) Figure 2017 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2018) (K Units) Table Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2018) Figure Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2017 Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2025 (K Units) Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2016-2025) (K Units) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Indonesia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Malaysia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Philippines Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Thailand Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Vietnam Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Singapore Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2018) (K Units) Table Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2018) Figure Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2017 Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2025 (K Units) Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2016-2025) (K Units) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2016-2025) (Million US$) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2018) (K Units) Table Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2018) Figure Central & South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2017 Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate 2016-2025 (K Units) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2016-2025) (K Units) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure GCC Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate (2016-2025) (K Units) Figure South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2016-2025) (K Units) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2016-2025) (K Units) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Company (2016-2018) (K Units) Table Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company (2016-2018) Figure Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Company in 2017 Table Astellas Pharmaceuticals Company Details Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Astellas Pharmaceuticals Recent Development Table Actavis Company Details Table Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Actavis Recent Development Table Pfizer Company Details Table Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Pfizer Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table GlaxoSmithKline Recent Development Table Salix Pharmaceuticals Ltd Company Details Table Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table Salix Pharmaceuticals Ltd Recent Development Table AstraZenenca Company Details Table AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018) Table AstraZenenca Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Value Chain Table Typical Suppliers of Key Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Material Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Customers List Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Channels Table Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Get Free Sample

Related Reports

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Insights, Forecast to 2025

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)